Nabi Biopharmaceuticals (NABI) Reports Q1 Loss of $0.03/Share

Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q1 EPS of ($0.03), versus $0.05 reported last year. Revenue for the quarter came in at $600 thousand, versus $9.17 million reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Terreno Realty Corp (TRNO) PT Raised to $75 at KeyBanc on 'Improving Demand'
• The Honest Co. (HNST) PT Raised to $5.70 at Morgan Stanley, 'Diaper Pressure Continues'